Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder

Completed · Phase 4

Conditions studied: Bipolar Disorder

In brief

This study evaluated whether lithium included as part of optimized medication treatment improved overall level of illness, symptoms of mania and depression, and quality of life in people with bipolar disorder.

Key facts

Study ID

NCT00667745

Run by

National Institute of Mental Health (NIMH)

People needed

283

Starts

2008-04-01

Expected to finish

2010-03-01

Last updated by the study team

2018-02-13

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets DSM-IV Criteria for bipolar disorder (type I or II)
• Currently symptomatic, as defined as a Clinical Global Impressions Scale-Bipolar Version, Overall Severity Index (CGI-BP-S) of greater than or equal to 3
• If taking or has taken lithium, must be off lithium for at least 30 days before study entry
• If a woman of child bearing potential, agrees to inform their doctor at the earliest possible time of their plans to conceive, to use adequate contraception (e.g. oral contraceptives, intrauterine device, barrier methods, total abstinence from intercourse), and to acknowledge the risks of lithium to the fetus and infant (Depo Provera is acceptable if it is started 3 months before study entry)

You may not qualify if…

• Renal impairment (serum creatinine greater than 1.5 mg/dL)
• Thyroid stimulating hormone (TSH) over 20% above the upper normal limit (participants maintained on thyroid medication must be euthyroid for at least 3 months before Visit 1)
• History of lithium toxicity that was not caused by mismanagement or overdose
• Other contraindication to lithium (e.g., hypersensitivity to lithium or any component of the formulation, severe cardiovascular or renal disease, severe debilitation, dehydration, sodium depletion, pregnancy)
• Currently in crisis such that inpatient hospitalization or other crisis - Participated in a clinical trial of an investigational drug within the 1 months before study entry
• Pregnant or breastfeeding

Where it is running

• Stanford University — Stanford, California, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• Case Western Reserve University — Cleveland, Ohio, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
• University of Texas Health Science Center — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.